CIK: 1256088 - Address: C/O Supernus Pharmaceuticals, Inc.,, 9715 Key West Avenue, Rockville, MD 20850
25 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/12/24 16:13
11/8/24
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsGemayel GeorgesMDDM.d12411.4601142713D
11/12/24 16:13
11/8/24
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsGemayel GeorgesMDDS.d-39236.300-11-4513D
11/8/24 16:11
11/7/24
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsGemayel GeorgesMDDM.d16311.4601413D
11/8/24 16:11
11/7/24
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsGemayel GeorgesMDDS.d-52036.620-14-5213D
9/17/24 16:10
9/13/24
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsGemayel GeorgesMDDS.d-43531.330-14-5113D
9/17/24 16:10
9/13/24
SUPNSupernus Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsGemayel GeorgesMDDM.d11511.4601030213D
8/7/20 16:48
8/5/20
MNTAMomenta Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagGemayel GeorgesMADM.d14814.8401024414D
8/7/20 16:48
8/5/20
MNTAMomenta Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagGemayel GeorgesMADS.d-33033.000-10-4214D
7/30/20 19:03
7/29/20
MNTAMomenta Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagGemayel GeorgesMADM.d14814.8401024414D
7/30/20 19:03
7/29/20
MNTAMomenta Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagGemayel GeorgesMADS.d-30030.000-10-4214D
6/21/19 16:16
6/20/19
MNTAMomenta Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagGemayel GeorgesMADM.d00.00044514D
6/22/18 18:00
6/20/18
MNTAMomenta Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagGemayel GeorgesMADM.d00.000614310D
2/14/14 20:32
2/13/14
NPSPNps Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagGemayel GeorgesNJDM.d00.000159D
2/14/14 20:32
2/13/14
NPSPNps Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagGemayel GeorgesNJDS.d-23337.700-6-419D
12/8/11 11:25
12/7/11
ADLRAdolor CorpHealthDrugPharmaceutical PreparationsGemayel GeorgesDM.d3822.1801750D
11/2/07 09:06
10/30/07
GENZGenzyme CorpMAHealthBioPrdBiological Products, (No DiagGemayel GeorgesMAOEVPM.d1,74046.3903814D
11/2/07 09:06
10/30/07
GENZGenzyme CorpMAHealthBioPrdBiological Products, (No DiagGemayel GeorgesMAOEVPS.d-2,85076.000-38-7314D
6/1/07 13:16
5/31/07
GENZGenzyme CorpMAHealthBioPrdBiological Products, (No DiagGemayel GeorgesMAOEVPM.d10043.90021914D
6/16/06 12:36
5/11/06
GENZGenzyme CorpMAHealthBioPrdBiological Products, (No DiagGemayel GeorgesMAOEVPP.a16956.4703509B
6/1/06 10:33
5/30/06
GENZGenzyme CorpMAHealthBioPrdBiological Products, (No DiagGemayel GeorgesMAOEVPM.d10043.90022511B
5/15/06 11:58
5/11/06
GENZGenzyme CorpMAHealthBioPrdBiological Products, (No DiagGemayel GeorgesMAOEVPP16956.4703509B
7/19/05 09:59
7/15/05
GENZGenzyme CorpMAHealthBioPrdBiological Products, (No DiagGemayel GeorgesMAOEVPM.d42543.900106D
7/19/05 09:59
7/15/05
GENZGenzyme CorpMAHealthBioPrdBiological Products, (No DiagGemayel GeorgesMAOEVPS.d-50868.610-7-576D
5/16/05 12:27
5/12/05
GENZGenzyme CorpMAHealthBioPrdBiological Products, (No DiagGemayel GeorgesMAOEVPM.d1,26046.180273D
5/16/05 12:27
5/12/05
GENZGenzyme CorpMAHealthBioPrdBiological Products, (No DiagGemayel GeorgesMAOEVPS.d-1,61364.500-25-893D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact